Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,802 INR | +0.66% |
|
+5.96% | +8.70% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.70% | 2.77B | |
-22.57% | 7.93B | |
+75.12% | 4.54B | |
-2.98% | 2.62B | |
-50.41% | 1.99B | |
-18.48% | 1.7B | |
-19.79% | 1.47B | |
+19.61% | 1.23B | |
-45.78% | 1.1B | |
+19.83% | 998M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505